We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




RPM Platform Helps Manage Gestational Diabetes

By HospiMedica International staff writers
Posted on 14 Sep 2021
A cellular-connected blood glucose remote patient monitoring (RPM) device provides simplified and improved patient care and support during pregnancy.

The Smart Meter (Tamps, FL, USA) iGlucose Blood Glucose Monitoring (BGM) system is an out-of-the-box ready device for patients of all ages that provides reliable and immediate cellular transmission of blood glucose readings via the proprietary AutoShare feature, thereby eliminating the need for logbooks, faxes, and avoidable phone calls. More...
In addition, Autoshare eliminates complicated Bluetooth pairing, syncing, and uploading by providing a seamless cellular connectivity experience.

Results can be viewed immediately by care providers, who can react in real-time to adjust diet or medication, potentially reducing care costs and trips to the hospital. The BGM is accompanied by the iGlucose virtual coach, which communicates with the user via text and email messages, reminders and alerts, notification of blood glucose results, and messages sent to engage the user’s circle of care. In addition, BGM includes the iGlucose personal web portal, which automatically generates logbook and reports.

“We've seen great success with our iGlucose monitors in other markets, such as long-term care (LTC), and we're thrilled to now offer our solution to support women with gestational diabetes,” said Casey Pittock, CEO of Smart Meter. “Pregnancy can be a stressful time. iGlucose can help provide peace of mind that patients are getting the best care and support possible.”

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. The definition applies whether insulin or only diet modification is used for treatment, and whether or not the condition persists after pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may have antedated or begun concomitantly with the pregnancy. About 7% of all pregnancies are complicated by GDM, with a prevalence of 1-14% of all pregnancies, depending on the population studied and the diagnostic tests employed.

Related Links:
Smart Meter


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Gynecological Examination Chair
arco-matic
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.